Nyrada Inc (ASX: $NYR) has requested a trading halt for its Chess Depositary Interests (CDIs) on the Australian Securities Exchange (ASX) in accordance with ASX Listing Rule 17.1. The trading halt is pending an announcement by the company regarding a proposed capital raising.
Nyrada Inc has requested a trading halt to manage its continuous disclosure obligations as it prepares to make an announcement to the market regarding a proposed capital raising. The company is committed to providing necessary information to inform the market about the trading halt and expects the halt to remain in place until the announcement is released or normal trading resumes on Wednesday, 6 March 2024.
Nyrada Inc, a drug discovery and development company focusing on novel small molecule drugs for neurological and cardiovascular diseases, has requested a trading halt in anticipation of a forthcoming announcement related to a proposed capital raising. The company's commitment to managing its continuous disclosure obligations reflects its dedication to transparent communication with the market. As Nyrada prepares for this announcement, investors and stakeholders may anticipate further developments in the company's capital structure and strategic initiatives.